Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Dyadic International, Inc. - Common Stock
(NQ:
DYAI
)
1.690
UNCHANGED
Streaming Delayed Price
Updated: 3:58 PM EST, Feb 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Dyadic International, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Dyadic Announces Research and Development Collaboration Agreement with Global Biopharmaceutical Company
February 06, 2024
From
Dyadic International, Inc.
Via
GlobeNewswire
Top 5 Active Stock Buzzers Under $10: INBS, PLUG, KOPN, DYAI, MINM
February 05, 2024
Via
AB Newswire
Dyadic to Attend BIO CEO & Investor Conference and European Industry Events
February 01, 2024
From
Dyadic International, Inc.
Via
GlobeNewswire
Latest Buzz on The Street: Noteworthy Developments at DYAI, ELEV, ATRA, ESPR, KAVL
January 17, 2024
Via
AB Newswire
Recap: Dyadic International Q3 Earnings
November 08, 2023
Via
Benzinga
“Revolutionizing Biotechnology: Dyadic International (NASDAQ: DYAI) Leads with C1 Platform for Swift and Efficient Protein Production”
January 11, 2024
Via
AB Newswire
Bull Run 2024: Biopharma Healthcare Stocks Surge, Gaining Momentum: DYAI, ABVC, FWBI, VTAK, NEXI
January 05, 2024
Via
AB Newswire
“Dyadic International Inc. (NASDAQ: DYAI): Zacks Small-Cap Research Indicates Valuation at $9.00 per Share”
January 05, 2024
Via
AB Newswire
“Dyadic International (NASDAQ: DYAI) Revolutionizing Pharma with Innovative C1 Technology for Global Protein Development”
January 02, 2024
Via
AB Newswire
Dyadic to Attend J.P. Morgan 42nd Annual Healthcare Conference
January 02, 2024
From
Dyadic International, Inc.
Via
GlobeNewswire
“2024 Market Outlook: SmallCap Radar Stocks Unveiled”: DYAI, SKYX, QUBT, KNW, VTAK
December 28, 2023
Via
AB Newswire
Topics
Intellectual Property
Exposures
Intellectual Property
“Dyadic International Inc. (NASDAQ: DYAI) Advances Biopharmaceutical Innovations and Vaccine Manufacturing Globally”
December 21, 2023
Via
AB Newswire
Exposures
COVID-19
CryptoNewsBreaks – Innovators and Ideas Showcased at 12th Annual Benchmark Discovery Conference
December 19, 2023
Via
Investor Brand Network
InvestorNewsBreaks – Standouts from 12th Annual Benchmark Discovery Conference Featured in Nasdaq Article
December 13, 2023
Via
Investor Brand Network
Dyadic Attends Investor Events in December
November 30, 2023
From
Dyadic International, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
November 29, 2023
Via
Benzinga
Dyadic Announces Top-Line Results from its Successful Phase 1 Clinical Trial for a First-in-Human Filamentous Fungal-Based Vaccine Candidate
November 29, 2023
From
Dyadic International, Inc.
Via
GlobeNewswire
Dyadic’s C1 Platform to be Used to Produce Vaccines for Humans and Animals in Africa
November 20, 2023
From
Dyadic International, Inc.
Via
GlobeNewswire
Dyadic to Present at Industry Events in November
October 30, 2023
From
Dyadic International, Inc.
Via
GlobeNewswire
Dyadic to Report Third Quarter 2023 Financial Results on Wednesday, November 8, 2023
October 25, 2023
From
Dyadic International, Inc.
Via
GlobeNewswire
Dyadic Appoints Doug Pace to Its Executive Leadership Team
October 09, 2023
From
Dyadic International, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
October 06, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 05, 2023
Via
Benzinga
Dyadic’s C1 Platform Selected by the Vaccine and Immunotherapy Center (“VIC”) at Massachusetts General Hospital as Part of VIC’s $5.88 Million Award by U.S. DoD to Develop a Self-Assembling Vaccine (SAV) Platform for Rapid Production of Prophylactic
October 05, 2023
From
Dyadic International, Inc.
Via
GlobeNewswire
Dyadic to Present at Industry and Investor Events in October
September 29, 2023
From
Dyadic International, Inc.
Via
GlobeNewswire
Dyadic and bYoRNA Announce a Collaboration Targeting the Production of Abundant, Low-Cost mRNA From C1-Cells
September 26, 2023
From
Dyadic International, Inc.
Via
GlobeNewswire
Dyadic Announces Development and License Agreement to Commercialize Animal-Free Alternative Proteins Using Dapibus™
September 19, 2023
From
Dyadic International, Inc.
Via
GlobeNewswire
Dyadic to Present at BioProcess International
September 12, 2023
From
Dyadic International, Inc.
Via
GlobeNewswire
Dyadic Announces Continued Progress Towards Commercialization of Animal-Free Recombinant Serum Albumin
August 07, 2023
From
Dyadic International, Inc.
Via
GlobeNewswire
Dyadic to Report Second Quarter 2023 Financial Results on Wednesday, August 9, 2023
July 26, 2023
From
Dyadic International, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
